Literature DB >> 24258279

Acute myocardial infarction hospitalization and treatment: Areas with a high percentage of First Nations identity residents.

Helen Ke Wei-Randall1, Mélanie Josée Davidson, Jing Jin, Sushma Mathur, Lisa Oliver.   

Abstract

BACKGROUND: Deaths from acute myocardial infarction (AMI) are higher among First Nations people than among non-Aboriginal Canadians. Hospital interventions often involve revascularization: percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). Because patients' ethnicity is not reported consistently in hospital records, no national information is available about AMI hospitalizations or the use of such procedures among First Nations people. DATA AND METHODS: This study uses an area-based approach to identify AMI hospital patients who live in Dissemination Areas with relatively high percentages of First Nations residents. Within the AMI patient cohort, procedures received during the hospital admission were identified.
RESULTS: The age-standardized hospitalized AMI event rates were 276.8 per 100,000 population for residents of high-percentage First Nations identity areas and 157.1 per 100,000 population for residents of low-percentage Aboriginal identity areas. AMI patients from high-percentage First Nations identity areas were less likely than patients from low-percentage Aboriginal identity areas to undergo revascularization, a difference largely driven by a lower PCI procedure rate. The lower PCI procedure rate persisted when controlling for age, sex, rural/urban residence, and the patient's condition at admission.
INTERPRETATION: Residents of high-percentage First Nations identity areas were more likely to be hospitalized for AMI, but were less likely to undergo revascularization.

Entities:  

Keywords:  Aboriginal health; coronary artery bypass; heart diseases; hospital records; myocardial ischemia; percutaneous coronary intervention; revascularization; small area variations

Mesh:

Year:  2013        PMID: 24258279

Source DB:  PubMed          Journal:  Health Rep        ISSN: 0840-6529            Impact factor:   4.796


  6 in total

1.  Postoperative outcomes for Indigenous Peoples in Canada: a systematic review.

Authors:  Jason A McVicar; Alana Poon; Nadine R Caron; M Dylan Bould; Jason W Nickerson; Nora Ahmad; Donna May Kimmaliardjuk; Chelsey Sheffield; Caitlin Champion; Daniel I McIsaac
Journal:  CMAJ       Date:  2021-05-17       Impact factor: 8.262

Review 2.  Access to Cardiovascular Care for Indigenous Peoples in Canada: A Rapid Review.

Authors:  Dominique Vervoort; Donna May Kimmaliardjuk; Heather J Ross; Stephen E Fremes; Maral Ouzounian; Angela Mashford-Pringle
Journal:  CJC Open       Date:  2022-06-04

3.  Time-trends and predictors of interhospital transfers and 30-day rehospitalizations after acute coronary syndrome from 2000-2015.

Authors:  J Afonso Rocha; José Carlos Cardoso; Alberto Freitas; Thomas G Allison; Luís F Azevedo
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

4.  Validation study of GRACE risk scores in indigenous and non-indigenous patients hospitalized with acute coronary syndrome.

Authors:  Pamela J Bradshaw; Judith M Katzenellenbogen; Frank M Sanfilippo; Michael S T Hobbs; Peter L Thompson; Sandra C Thompson
Journal:  BMC Cardiovasc Disord       Date:  2015-11-16       Impact factor: 2.298

5.  Exploring the effects of transfers and readmissions on trends in population counts of hospital admissions for coronary heart disease: a Western Australian data linkage study.

Authors:  Derrick Lopez; Lee Nedkoff; Matthew Knuiman; Michael S T Hobbs; Thomas G Briffa; David B Preen; Joseph Hung; John Beilby; Sushma Mathur; Anna Reynolds; Frank M Sanfilippo
Journal:  BMJ Open       Date:  2017-11-17       Impact factor: 2.692

6. 

Authors:  Jason A McVicar; Alana Poon; Nadine R Caron; M Dylan Bould; Jason W Nickerson; Nora Ahmad; Donna May Kimmaliardjuk; Chelsey Sheffield; Caitlin Champion; Daniel I McIsaac
Journal:  CMAJ       Date:  2021-08-23       Impact factor: 8.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.